Announcing New Projects in Translational Research
January 2, 2024
We are pleased to announce that we have made our first series of investments and grants to organizations developing novel devices and technologies that improve outcomes for single ventricle patients.
To date, we’ve invested in the following companies:
- FluidForm – a tissue engineering company working towards creating therapeutic-scale tissues.
- StarBP – a multi-use ventricular assist device company developing new devices for individuals with Fontan circulation.
- Renata Medical – a growth stent company creating new devices for our single ventricle population.
We are dedicated to improving and expanding treatment options for single ventricle patients. These investments offer exciting new avenues to support translation of discoveries from bench to bedside by funding projects focused on bringing products to the next stage of development.
Subscribe for Updates
We’ll keep you posted about our work across Additional Ventures.